Thrombotic Storm Revisited: Preliminary Diagnostic Criteria Suggested by the Thrombotic Storm Study Group

被引:33
作者
Kitchens, Craig S. [1 ]
Erkan, Doruk [2 ]
Brandao, Leonardo R. [3 ]
Hahn, Susan [4 ]
James, Andra H. [5 ]
Kulkarni, Roshni [6 ]
Pericak-Vance, Margaret [4 ]
Vance, Jeffery [4 ]
Ortel, Thomas L. [5 ]
机构
[1] Univ Florida, Gainesville, FL 32610 USA
[2] Cornell Univ, Hosp Special Surg, Weill Med Coll, New York, NY 10021 USA
[3] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[4] Univ Miami, John P Hussman Inst Human Gen, Coral Gables, FL 33124 USA
[5] Duke Univ, Med Ctr, Durham, NC USA
[6] Michigan State Univ, E Lansing, MI 48824 USA
关键词
Catastrophic antiphospholipid syndrome; Hypercoagulability; Thrombosis; Thrombotic storm; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; VON-WILLEBRAND-FACTOR; HEPARIN-INDUCED THROMBOCYTOPENIA; CLEAVING PROTEASE; HELLP-SYNDROME; PREECLAMPSIA; ASSOCIATION; DEFICIENCY; ADAMTS13; FAILURE;
D O I
10.1016/j.amjmed.2010.10.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Physicians periodically encounter patients with an extraordinarily accelerated course of hypercoagulability who develop thromboses in multiple organ systems over days to weeks. Such patients may harbor underlying hypercoagulable clinical conditions, but their clinical course sets them apart from most patients with similar risk factors. Underlying triggers of "thrombotic storm" include pregnancy, inflammation, trauma, surgery, and infection. Aggressive anticoagulant therapy may control thrombotic storm, yet thrombotic storm may resume with even brief interruptions of anticoagulant therapy. The authors of this communication formed the Thrombotic Storm Study Group in order to identify clinical characteristics of such patients, thus constructing preliminary criteria to better define, identify, and study the course of patients deemed to have thrombotic storm. The characteristics culled from these 10 patients are: younger age (oldest was 38 years old at time of presentation); at least 2 arterial or venous (or both) thromboembolic events, typically in unusual sites with or without microangiopathy; unexplained recurrence; and frequently proceeded by a trigger. The following characteristics were not used in defining thrombotic storm: underlying malignancies; use of acute myocardial infarction as a defining arterial event in the setting of established coronary artery disease; use of cocaine; thrombotic complications expected with various intravascular devices; known paroxysmal nocturnal hemoglobinuria or myeloproliferative disorders; severe trauma; and premorbid conditions. (C) 2011 Elsevier Inc. All rights reserved. The American Journal of Medicine (2011) 124, 290- 296
引用
收藏
页码:290 / 296
页数:7
相关论文
共 36 条
  • [1] Circulating microparticles, lupus anticoagulant and recurrent miscarriages
    Alijotas-Reig, Jaume
    Palacio-Garcia, Carles
    Vilardell-Tarres, Miquel
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 145 (01) : 22 - 26
  • [2] The catastrophic antiphospholipid syndrome 1996: Acute multi-organ failure associated with antiphospholipid antibodies: A review of 31 patients
    Asherson, RA
    Piette, JC
    [J]. LUPUS, 1996, 5 (05) : 414 - 417
  • [3] Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry
    Avcin, Tadej
    Cimaz, Rolando
    Silverman, Earl D.
    Cervera, Ricard
    Gattorno, Marco
    Garay, Stella
    Berkun, Yackov
    Sztajnbok, Flavio R.
    Silva, Clovis A.
    Campos, Lucia M.
    Saad-Magalhaes, Claudia
    Rigante, Donato
    Ravelli, Angelo
    Martini, Alberto
    Rozman, Blaz
    Meroni, Pier Luigi
    [J]. PEDIATRICS, 2008, 122 (05) : E1100 - E1107
  • [4] HELLP syndrome: The state of the art
    Baxter, JSK
    Weinstein, L
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2004, 59 (12) : 838 - 845
  • [5] Sepsis as a model of SIRS
    Bhatia, Madhav
    He, Min
    Zhang, Huili
    Moochhala, Shabbir
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 4703 - 4711
  • [6] Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature
    Bortolati, Maria
    Marson, Piero
    Fabris, Fabrizio
    Pengo, Vittorio
    Facchinetti, Myriam
    De Silvestro, Giustina
    Ruffatti, Amelia
    [J]. AUTOIMMUNITY REVIEWS, 2009, 8 (04) : 297 - 301
  • [7] Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the "CAPS Registry"
    Cervera, Ricard
    Bucciarelli, Silvia
    Plasin, Miguel A.
    Gomez-Puerta, Jose A.
    Plaza, Joan
    Pons-Estel, Guillermo
    Shoenfeld, Yehuda
    Ingelmo, Miguel
    Espinos, Gerard
    [J]. JOURNAL OF AUTOIMMUNITY, 2009, 32 (3-4) : 240 - 245
  • [8] Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?
    Clark E.A.S.
    Silver R.M.
    Branch D.W.
    [J]. Current Rheumatology Reports, 2007, 9 (3) : 219 - 225
  • [9] Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure
    Claus, Ralf A.
    Bockmeyer, Clemens L.
    Budde, Ulrich
    Kentouche, Karim
    Sossdorf, Maik
    Hilberg, Thomas
    Schneppenheim, Reinhart
    Reinhart, Konrad
    Bauer, Michael
    Brunkhorst, Frank M.
    Loesche, Wolfgang
    [J]. THROMBOSIS AND HAEMOSTASIS, 2009, 101 (02) : 239 - 247
  • [10] Coppola R, 2003, HAEMATOLOGICA, V88, P39